“…Among the included studies, 28 were prospective studies [21-25, 29, 38-40, 42, 44, 48, 51, 53, 56, 58-62, 64, 65, 68, 70, 71, 74-76], 19 were retrospective series [2, 8, 13-15, 18, 26-28, 33, 43, 45, 57, 63, 66, 67, 69, 72, 73], and 19 were randomized clinical trials (RCT) [16, 17, 19, 20, 30-32, 34-37, 41, 46, 47, 49, 50, 52, 54, 55] (Tables 1-2). The quality of the studies was generally low with a consistent risk of bias; the median score of the Jadad Scale for RCT was 3 (1-5), and only 2 studies had the highest possible score [52,55]; the median MINORS score for non-comparative studies was 12 (3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16), with only one study that could be regarded as excellent [44], while the median MINORS score for comparative studies was 17 (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21) (Tables 1, 2). Risk of bias of the selected studies could be attributed mainly to a retrospective design, difficulty or impossibility of patients' and operators' blinding, small sample size, short follow-up, heterogeneity of the analyzed variables, absence of uniform definition of the main outcomes (success rate, continence impairment).…”